tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Positive Outlook for Talphera: Buy Rating Backed by Promising Niyad Trial Progress and Strong Financial Position
PremiumRatingsPositive Outlook for Talphera: Buy Rating Backed by Promising Niyad Trial Progress and Strong Financial Position
2M ago
Talphera Reports Q2 2025 Financial Results and Study Progress
Premium
Company Announcements
Talphera Reports Q2 2025 Financial Results and Study Progress
2M ago
Talphera reports Q2 EPS (10c) vs. (15c) last year
Premium
The Fly
Talphera reports Q2 EPS (10c) vs. (15c) last year
2M ago
Talphera, Inc. Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsTalphera, Inc. Reports Q1 2025 Financial Results
5M ago
Talphera reports Q1 EPS (10c), consensus (14c)
Premium
The Fly
Talphera reports Q1 EPS (10c), consensus (14c)
5M ago
Talphera sees 2025 expenses $17M-$19M
Premium
The Fly
Talphera sees 2025 expenses $17M-$19M
5M ago
Talphera reports Q4 EPS (7c) vs. (25c) last year
PremiumThe FlyTalphera reports Q4 EPS (7c) vs. (25c) last year
6M ago
Talphera announces agreement with FDA to reduce NEPHRO CRRT study size
Premium
The Fly
Talphera announces agreement with FDA to reduce NEPHRO CRRT study size
6M ago
Talphera, Inc. (TLPH) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Talphera, Inc. (TLPH) Q4 Earnings Cheat Sheet
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100